tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CYCC Stock Latest News

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
Press ReleasesCyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
1d ago
CYCC
Cyclacel Pharmaceuticals files to sell 15.2M shares of common stock for holders
PremiumThe Fly
Cyclacel Pharmaceuticals files to sell 15.2M shares of common stock for holders
3d ago
CYCC
CYCC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CYCC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3d ago
CYCC
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
6d ago
EBS
AMRN
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules
PremiumPress Releases
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules
7d ago
CYCC
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
7d ago
ALT
APLS
Cyclacel Pharmaceuticals to sell 4.97M shares at $1.61 in private placement
PremiumThe Fly
Cyclacel Pharmaceuticals to sell 4.97M shares at $1.61 in private placement
9d ago
CYCC
Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
PremiumPress Releases
Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
9d ago
CYCC
Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer
PremiumPress Releases
Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer
1M ago
CYCC
Cyclacel Pharmaceuticals reports Q4 EPS (6.23), consensus ($5.89)
PremiumThe Fly
Cyclacel Pharmaceuticals reports Q4 EPS (6.23), consensus ($5.89)
2M ago
CYCC
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2M ago
CYCC
Is CYCC a Buy, Before Earnings?
PremiumPre-Earnings
Is CYCC a Buy, Before Earnings?
2M ago
CYCC
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
PremiumPress ReleasesCyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
2M ago
CYCC
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
PremiumPress Releases
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
2M ago
CYCC
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
PremiumPress Releases
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
2M ago
CYCC
Cyclacel Pharmaceuticals receives $2.9M R&D tax credit
PremiumThe Fly
Cyclacel Pharmaceuticals receives $2.9M R&D tax credit
2M ago
CYCC
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference
PremiumPress Releases
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference
3M ago
CYCC
Cyclacel Pharmaceuticals Appoints New Interim Chief Medical Officer
PremiumCompany Announcements
Cyclacel Pharmaceuticals Appoints New Interim Chief Medical Officer
3M ago
8K
CYCC
Cyclacel Pharmaceuticals Announces Chief Medical Officer Termination
PremiumCompany Announcements
Cyclacel Pharmaceuticals Announces Chief Medical Officer Termination
3M ago
8K
CYCC
Cyclacel terminates CMO Kirschbaum, appoints Schwartz as interim CMO
PremiumThe FlyCyclacel terminates CMO Kirschbaum, appoints Schwartz as interim CMO
3M ago
CYCC
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
PremiumPress Releases
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
3M ago
CYCC
Cyclacel Pharmaceuticals files to sell 411,969 shares of common stock for holder
PremiumThe Fly
Cyclacel Pharmaceuticals files to sell 411,969 shares of common stock for holder
4M ago
CYCC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >